Library / Laws / 119th Congress / Senate Bills / S. 1414
S. 1414
To amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2025-04-10 | 2.3K | ⠃⠗⠋ |
| Reported in Senate | 2026-07-27 | 6.1K | ⠃⠗⠋ |